Past Event

Join us for the upcoming – DaRe2THINK Webinar

This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.

This webinar will describe a scalable, end-to-end, digital pathway for the detection of atrial fibrillation in the community.

Speaker: Professor Chris Gale
BSc (Hons), MB;BS, Ph.D, MEd, MSc, FESC, FRCP

Chris Gale is Professor of Cardiovascular Medicine at the University of Leeds and Honorary Consultant Cardiologist at Leeds General Infirmary. He is a leading trialist and health services researcher with expertise in cardiovascular care and outcomes, holding major research awards from NIHR and the British Heart Foundation. He has published extensively in top journals, including JAMA and The Lancet, and serves as Clinical Lead for the UK nationwide heart attack register (MINAP). Chris is a Fellow of the Royal College of Physicians and the European Society of Cardiology, and Co-Chair of The Lancet Regional Health – Europe Commission on Inequalities in Cardiovascular Health.

DaRe2THINK

This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.

DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the time taken for research, both for the patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.

Webinar schedule:

12:30 – 12:45 – Presentation by Prof Chris Gale

12:45 – 12:55 – Q&A and discussion

12:55 – 13:00 – The DaRe2THINK trial

Key benefits:

Continuing Professional Development
Learn from academic healthcare professionals (HCPs)
Be informed of relevant published findings
Engage in discussions with other HCPs
Exclusive insight into an ongoing national trial
Find out how to get involved yourself!

Join us for the upcoming – DaRe2THINK Webinar

This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.

Everyone knows that cholesterol is a major risk factor for cardiovascular disease. 30 years ago the west of Scotland Cory prevention Study showed for the first time that primary prevention of cardiovascular disease by lowering cholesterol levels reduced major adverse cardiovascular events. However, lowering LDL cholesterol by many other ways is now possible and future therapies are coming. This talk will review the state of the art of lipids with a glimpse into the future.

Speaker: Professor Derek Connolly
BSc[Hons] MB ChB[Edin] PhD[Cantab] DSc[Hon] FRCP FRCPE FESC
Consultant Cardiologist, The Midland Metropolitan University Hospital, Birmingham

Professor Derek Connolly is a Consultant Cardiologist at the Midland Metropolitan University Hospital, the Priory Hospital, and the Birmingham City and Sandwell Health Campuses in Birmingham, UK. He holds honorary academic positions at both Aston University and at the Institute of Cardiovascular Sciences, University of Birmingham, UK. He has been on the council of the UK Primary Care Cardiovascular Society, which has nearly 7000 members, since its rebirth in 2019.

He trained in Edinburgh, Cambridge, London and San Diego where he was a Carnegie Scholar. He has a first class degree in Pharmacology from the University of Edinburgh where he was the Brunton medallist and the Keasbey Bursary holder. His BHF funded PhD in molecular cardiology is from the University of Cambridge. He is the Chief or Primary Investigator of multiple large trials in Cardiovascular medicine. He was awarded an honorary doctorate by Aston University for his contributions to medical science where in December 2024 was appointed as the Vice-Chancellor’s Professorial Fellow in Health Research

DaRe2THINK

This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.

DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the time taken for research, both for the patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.

Webinar schedule:

13:00 – 13:15 – Presentation by Prof Derek Connolly

13:15 – 13:25 – Q&A and discussion

13:25 – 13:30 – The DaRe2THINK trial

Key benefits:

Continuing Professional Development
Learn from academic healthcare professionals (HCPs)
Be informed of relevant published findings
Engage in discussions with other HCPs
Exclusive insight into an ongoing national trial
Find out how to get involved yourself!

Join us for the upcoming – DaRe2THINK Webinar

This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.

Professor Taylor was a member of the NICE chronic heart failure guideline update committee. She will give an overview of the updated NICE recommendations on the treatment of chronic heart failure.

Speaker: Professor Clare Taylor MBE PhD FRCGP

Professor Clare Taylor is a Professor of General Practice at the University of Birmingham and a General Practitioner working in the NHS.

Professor Taylor’s research focuses on earlier diagnosis and improving prognosis for people with heart failure in primary care using big GP datasets. Professor Taylor has received grant and fellowship funding from the National Institute for Health and Care Research, Wellcome Trust, and British Heart Foundation. She has published over 100 peer-reviewed papers in high-impact journals, including British Medical Journal and European Heart Journal, and her research has informed international heart failure guidelines.

Professor Taylor was made a Member of the Order of the British Empire (MBE) for services to General Practice in 2015 and was recently awarded the prestigious RCGP John Fry Award 2023 for promoting the discipline of general practice through research and publishing.

DaRe2THINK

This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.

DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the time taken for research, both for the patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.

Webinar schedule:

12:30 – 12:45 – Presentation by Professor Clare Taylor MBE

12:45 – 12:55 – Q&A and discussion

12:55 – 13:00 – The DaRe2THINK trial

Key benefits:

Continuing Professional Development
Learn from academic healthcare professionals (HCPs)
Be informed of relevant published findings
Engage in discussions with other HCPs
Exclusive insight into an ongoing national trial
Find out how to get involved yourself!

Join us for the upcoming – DaRe2THINK Webinar

This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.

The latest European Society guidelines for atrial fibrillation emphasise the importance of patient engagement at every stage of their management. This is highlighted in the new patient-centred integrated AF – CARE algorithm in which the management of co morbidities and risk factors are given high priority. This talk will discuss the way in which the AF patient guidelines can assist in bridging the gap between the evidence base and its practical application in day to day patient care.

Speaker: Dr Jeremy Dwight

Dr Jeremy Dwight is a member of the ESC patient forum and patient representative on the ESC AF Guidelines Task Force. He is also a Retired Cardiologist (John Radcliffe Hospital Oxford) and Senior Lecturer in Cardiovascular medicine Keble College, Oxford University.

DaRe2THINK

This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.

DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the time taken for research, both for the patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.

Webinar schedule:

12:00 – 12:15 – Presentation by Dr Jeremy Dwight

12:15 – 12:25 – Q&A and discussion

12:25 – 12:30 – The DaRe2THINK trial

Key benefits:

Continuing Professional Development
Learn from academic healthcare professionals (HCPs)
Be informed of relevant published findings
Engage in discussions with other HCPs
Exclusive insight into an ongoing national trial
Find out how to get involved yourself!

Join us for the upcoming – DaRe2THINK Webinar

This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.

This talk provides a practical update on how wearable devices detect atrial fibrillation (AF), and how to interpret alerts in a clinical context. It offers information on what steps to take when a patient presents with a watch/device-detected AF episode, in the context of the 2024 ESC Guidelines on AF.

Speaker: Dr Emma Svennberg

Dr. Emma Svennberg is an Assistant Professor, Electrophysiologist, and Head of Specialty Training at the Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden. Her primary research interests focus on atrial fibrillation (AF) screening, particularly systematic approaches, where she has played a key role in the large population-based screening studies STROKESTOP I & II. 

Dr. Svennberg has been recognized with the Swedish Society of Cardiology Research Award twice and holds fellowships with the European Society of Cardiology (ESC) and the European Heart Rhythm Association (EHRA). She was a founding member and later President of the Swedish branch of Cardiologists of Tomorrow. In 2024, she was elected Treasurer of the EHRA board and currently serves on its Executive Board. She was also part of the ESC 2024 Task Force for the Atrial Fibrillation Guidelines.

DaRe2THINK

This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.

DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the time taken for research, both for the patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.

Webinar schedule:

12:00 – 12:15 – Presentation by Dr Emma Svennberg

12:15 – 12:25 – Q&A and discussion

12:25 – 12:30 – The DaRe2THINK trial

Key benefits:

• Continuing Professional Development
• Learn from academic healthcare professionals (HCPs)
• Be informed of relevant published findings
• Engage in discussions with other HCPs
• Exclusive insight into an ongoing national trial
• Find out how to get involved yourself!

Join us for the upcoming – DaRe2THINK Webinar:

This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.

This talk will summarise the latest evidence on the importance of blood pressure lowering. It will address some of the less-well known effects of antihypertensive therapy on various health outcomes and contrast them with LDL-lowering therapy.

Speaker: Dr Kazem Rahimi FRCP DM MSc FESC

Kazem Rahimi is a Professor of Cardiovascular Medicine and Population Health, at the University of Oxford and a consultant cardiologist at the Oxford University Hospitals NHS Trust. Kazem leads the Deep Medicine programme at the Nuffield Department of Women’s and Reproductive Health with a major interest in application of machine learning approaches to electronic health records. He also leads the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC), which is an international collaboration of all the major trials of blood pressure lowering drugs.

DaRe2THINK

This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.

DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the time taken for research, both for the patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.

Webinar schedule:

12:00 – 12:15 – Presentation by Dr Kazem Rahimi

12:15 – 12:25 – Q&A and discussion

12:25 – 12:30 – The DaRe2THINK trial

Key benefits:

• Continuing Professional Development
• Learn from academic healthcare professionals (HCPs)
• Be informed of relevant published findings
• Engage in discussions with other HCPs
• Exclusive insight into an ongoing national trial
• Find out how to get involved yourself!

Join us for the upcoming – DaRe2THINK Webinar:

Can focused education for healthcare professionals improve the care of patients with atrial fibrillation?

This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.

Speaker: Dr Karina V Bunting PhD MSc BSc

Dr Karina V Bunting is a research fellow at the University of Birmingham and a highly specialised cardiac physiologist in echocardiography at the University Hospitals Birmingham NHS Foundation Trust. Her work focusses on improving the assessment of heart function in patients with atrial fibrillation (AF). Dr Bunting has a wider interest in improving the management of patients with atrial fibrillation and heart failure which began as the research fellow for the RATE-AF trial (recently published in a top medical journal) . She has collaborated with leaders in heart failure and atrial fibrillation, including the Beta-blocker and heart failure collaborative group and more recently helping coordinate the European Society of Cardiology funded Stroke prevention and rhythm control Therapy: Evaluation of an Educational Programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation (STEEER-AF) trial.

DaRe2THINK

This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.

DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the time taken for research, both for the patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.

Webinar schedule:

12:00 – 12:15 – Presentation by Dr Karina V Bunting PhD MSc BSc

12:15 – 12:25 – Q&A and discussion

12:25 – 12:30 – The DaRe2THINK trial

Key benefits:

Continuing Professional Development
Learn from academic healthcare professionals (HCPs)
Be informed of relevant published findings
Engage in discussions with other HCPs
Exclusive insight into an ongoing national trial
Find out how to get involved yourself!